Skip to Main Content

Paper Details

Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies.
Biomed Res Int
19
2017
Author NameAffiliation
Michael RudnickiMedical University Innsbruck
  • 1 - 1

Datasets

Release 1.2